E. Zipperer

751 total citations
7 papers, 301 citations indexed

About

E. Zipperer is a scholar working on Hematology, Genetics and Emergency Medicine. According to data from OpenAlex, E. Zipperer has authored 7 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Genetics and 3 papers in Emergency Medicine. Recurrent topics in E. Zipperer's work include Acute Myeloid Leukemia Research (6 papers), Hematological disorders and diagnostics (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). E. Zipperer is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hematological disorders and diagnostics (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). E. Zipperer collaborates with scholars based in Germany, Italy and United Kingdom. E. Zipperer's co-authors include Corinna Strupp, A. Kuendgen, Erica Travaglino, Rosangela Invernizzi, Matteo Giovanni Della Porta, Ilaria Ambaglio, Luca Malcovati, C. Pascutto, Mario Lazzarino and Mario Cazzola and has published in prestigious journals such as Blood, Haematologica and Leukemia Research.

In The Last Decade

E. Zipperer

7 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Zipperer Germany	5	283	162	53	50	31	7	301
Corinna Strupp Germany	5	464 1.6×	268 1.7×	77 1.5×	71 1.4×	49 1.6×	7	485
Fabiana Gentilini Italy	10	232 0.8×	91 0.6×	16 0.3×	13 0.3×	73 2.4×	22	296
F Page Australia	4	170 0.6×	47 0.3×	48 0.9×	20 0.4×	27 0.9×	5	225
H. P. Muller Netherlands	7	243 0.9×	114 0.7×	27 0.5×	14 0.3×	7 0.2×	11	278
Kaito Harada Japan	9	189 0.7×	28 0.2×	84 1.6×	14 0.3×	59 1.9×	46	252
M. Angeles Soler Spain	11	240 0.8×	133 0.8×	29 0.5×	5 0.1×	46 1.5×	14	296
Maria Åström Sweden	11	217 0.8×	68 0.4×	152 2.9×	12 0.2×	81 2.6×	22	306
Boris Labar Croatia	7	286 1.0×	42 0.3×	124 2.3×	14 0.3×	111 3.6×	17	391
Stefanie Jilg Germany	6	140 0.5×	53 0.3×	43 0.8×	6 0.1×	30 1.0×	15	219
Ole Maywald Germany	7	142 0.5×	89 0.5×	21 0.4×	9 0.2×	20 0.6×	11	209

Countries citing papers authored by E. Zipperer

Since Specialization

Citations

This map shows the geographic impact of E. Zipperer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Zipperer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Zipperer more than expected).

Fields of papers citing papers by E. Zipperer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Zipperer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Zipperer. The network helps show where E. Zipperer may publish in the future.

Co-authorship network of co-authors of E. Zipperer

This figure shows the co-authorship network connecting the top 25 collaborators of E. Zipperer. A scholar is included among the top collaborators of E. Zipperer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Zipperer. E. Zipperer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Zipperer, E., Corinna Strupp, Andrea Kündgen, et al.. (2014). The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system. Haematologica. 99(3). e31–e32. 25 indexed citations

2.

Zipperer, E., Matthias Herkert, Andrea Kündgen, et al.. (2013). Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Annals of Hematology. 92(12). 1617–1623. 30 indexed citations

3.

Schroeder, Thomas, Julia Fröbel, Ron‐Patrick Cadeddu, et al.. (2012). Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation. Blood. 120(21). 1964–1964. 1 indexed citations

4.

Zipperer, E., Katy Graef, Andrea Kündgen, et al.. (2011). 325 Validation of the ‘Texas Score’ for the prognostication of patients with myelodysplastic syndromes. Leukemia Research. 35. S130–S130. 1 indexed citations

5.

Porta, Matteo Giovanni Della, Luca Malcovati, Corinna Strupp, et al.. (2010). Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematologica. 96(3). 441–449. 164 indexed citations

6.

Zipperer, E., Kathrin Nachtkamp, A. Kuendgen, et al.. (2009). The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome. Haematologica. 94(5). 729–732. 64 indexed citations

7.

Porta, Matteo Giovanni Della, Andrea Kuendgen, Luca Malcovati, et al.. (2008). Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS. Blood. 112(11). 2677–2677. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact